1 |
Vanhelst J, Béghin L, Drumez E, Djeddi-Dine D, Tuck D, Coopman S, Gottrand F, Ley D. Validation of the IMPACT-III Questionnaire in French Children With Inflammatory Bowel Disease. J Pediatr Gastroenterol Nutr 2023;76:e71-6. [PMID: 36735394 DOI: 10.1097/MPG.0000000000003716] [Reference Citation Analysis]
|
2 |
Grant A, Otley A. Measurement of Quality of Life in Pediatric Inflammatory Bowel Disease. Pediatric Inflammatory Bowel Disease 2023. [DOI: 10.1007/978-3-031-14744-9_51] [Reference Citation Analysis]
|
3 |
Yu-Ting Y, Miao Y, Yong-Wei Y, Qiong Y, Ting L. Relationships between children-related factors, basic psychological need satisfaction, and multiple happiness among urban empty-nesters in China: a structural equation modeling. BMC Geriatr 2022;22:925. [PMID: 36457076 DOI: 10.1186/s12877-022-03640-0] [Reference Citation Analysis]
|
4 |
Fedele F, Martinelli M, Strisciuglio C, Dolce P, Giugliano FP, Scarpato E, Staiano A, Miele E. Health-Related Quality of Life in Pediatric Inflammatory Bowel Disease During COVID-19 Pandemic: A Prospective Study. J Pediatr Gastroenterol Nutr 2022;75:595-600. [PMID: 35897141 DOI: 10.1097/MPG.0000000000003576] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
5 |
Alhadab AA, AlMahamed SN, Hassan IE, Hammo AH. The impact of inflammatory bowel diseases on the quality of life of Saudi pediatric patients: A cross-sectional study. Saudi J Gastroenterol 2022;28:448-55. [PMID: 35946259 DOI: 10.4103/sjg.sjg_162_22] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
6 |
Gordon RJ, Wells R, Johansen C, Liu S, Dahlberg SE, Snapper SB, Rufo PA. Efficacy and Safety of High-dose Cholecalciferol in Patients With Inflammatory Bowel Disease Receiving Infliximab. J Pediatr Gastroenterol Nutr 2022;74:476-83. [PMID: 35045559 DOI: 10.1097/MPG.0000000000003386] [Reference Citation Analysis]
|
7 |
Oba J, Sobrado CW, Damião AOMC, Azevedo M, Carlos A, Queiroz N, Len CA, Toma RK, Deboni M, Ozaki MJ, Carrilho FJ, Nahas S, Silva CA. HEALTH-RELATED QUALITY OF LIFE IN ADOLESCENTS AND YOUNG ADULTS WITH INFLAMMATORY BOWEL DISEASE IS ASSOCIATED WITH REDUCTION IN SCHOOL AND WORK PRODUCTIVITY RATHER THAN PHYSICAL IMPAIRMENT: A MULTIDISCIPLINARY STUDY. Arq Gastroenterol 2021;58:541-7. [PMID: 34909863 DOI: 10.1590/S0004-2803.202100000-96] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
8 |
Gatti S, Del Baldo G, Catassi G, Faragalli A, Aloi M, Bramuzzo M, D'Arcangelo G, Felici E, Fuoti M, Lega S, Panceri R, Pastore M, Penagini F, Gesuita R, Catassi C. Factors associated with quality of life in Italian children and adolescents with IBD. Sci Rep 2021;11:18076. [PMID: 34508152 DOI: 10.1038/s41598-021-97661-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
9 |
Tempchin J, Storch B, Reigada LC. Systematic review: Psychosocial factors of resilience in young people with inflammatory bowel disease. J Psychosom Res 2021;148:110558. [PMID: 34280678 DOI: 10.1016/j.jpsychores.2021.110558] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|
10 |
Brenner EJ, Long MD, Mann CM, Lin L, Chen W, Reyes C, Bahnson KM, Reeve BB, Kappelman MD. Validity and Responsiveness of the Patient-reported Outcomes Measurement Information System in Children With Ulcerative Colitis. J Pediatr Gastroenterol Nutr 2021;73:67-72. [PMID: 33633083 DOI: 10.1097/MPG.0000000000003101] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
11 |
Cushman G, Stolz MG, Shih S, Listernick Z, Talmadge C, Gold BD, Reed B. Age, Disease Symptoms, and Depression are Associated With Body Image Dissatisfaction in Newly Diagnosed Pediatric Inflammatory Bowel Disease. J Pediatr Gastroenterol Nutr 2021;72:e57-62. [PMID: 32925551 DOI: 10.1097/MPG.0000000000002943] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
|
12 |
Scheffers LE, Helbing WA, Utens EMWJ, Dieleman GC, Dulfer K, Noske J, van den Broek EA, Walet S, Olieman JF, Escher JC, Pijnenburg MW, van der Ploeg AT, van den Berg LE. Study Protocol of the Exercise Study: Unraveling Limitations for Physical Activity in Children With Chronic Diseases in Order to Target Them With Tailored Interventions-A Randomized Cross Over Trial. Front Pediatr 2021;9:791701. [PMID: 35118031 DOI: 10.3389/fped.2021.791701] [Reference Citation Analysis]
|
13 |
Grossman A, Mauer E, Gerber LM, Long MD, Kappelman MD, Gupta N. Black/African American Patients with Pediatric Crohn's Disease Report Less Anxiety and Fatigue than White Patients. J Pediatr 2020;225:146-51. [PMID: 32544479 DOI: 10.1016/j.jpeds.2020.05.042] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
14 |
Grant A, MacIntyre B, Kappelman MD, Otley AR. A New Domain Structure for the IMPACT-III Health-related Quality of life Tool for Pediatric Inflammatory Bowel Disease. J Pediatr Gastroenterol Nutr 2020;71:494-500. [PMID: 32960540 DOI: 10.1097/MPG.0000000000002824] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
15 |
Aardoom MA, Kemos P, Tindemans I, Aloi M, Koletzko S, Levine A, Turner D, Veereman G, Neyt M, Russell RK, Walters TD, Ruemmele FM, Samsom JN, Croft NM, de Ridder L; PIBD-SETQuality consortium and PIBD-NET. International prospective observational study investigating the disease course and heterogeneity of paediatric-onset inflammatory bowel disease: the protocol of the PIBD-SETQuality inception cohort study. BMJ Open 2020;10:e035538. [PMID: 32611739 DOI: 10.1136/bmjopen-2019-035538] [Reference Citation Analysis]
|
16 |
Brenner EJ, Long MD, Mann CM, Chen W, Reyes C, Lin L, Reeve BB, Kappelman MD. Responsiveness of the Patient-reported Outcomes Measurement Information System (PROMIS) Pediatric Measures to Changes in Disease Status and Quality of Life Among Children and Adolescents With Crohn's Disease. Inflamm Bowel Dis 2021;27:344-51. [PMID: 32435792 DOI: 10.1093/ibd/izaa083] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
17 |
Jafari S, Otley A, Vahed H, Heidari E, Khakshour A, Tehranian S, Mehdizadeh A, Shojaei P, Kianifar H, Day AS, Sayedi J. Validation of the Persian Version of IMPACT-III Quality of Life Questionnaire in Iranian Children with Inflammatory Bowel Disease. Iran J Pediatr 2020;30. [DOI: 10.5812/ijp.86281] [Reference Citation Analysis]
|
18 |
Cushman GK, Stolz MG, Shih S, Blount R, Otley A, Talmadge C, Grant A, Reed B. Parent IMPACT-III: Development and Validation of an Inflammatory Bowel Disease-specific Health-related Quality-of-life Measure. J Pediatr Gastroenterol Nutr 2020;70:205-10. [PMID: 31978018 DOI: 10.1097/MPG.0000000000002540] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
19 |
Beese SE, Harris IM, Dretzke J, Moore D. Body image dissatisfaction in patients with inflammatory bowel disease: a systematic review. BMJ Open Gastroenterol 2019;6:e000255. [PMID: 30899537 DOI: 10.1136/bmjgast-2018-000255] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
|
20 |
Kim S, Park S, Kang Y, Kim JE, Kang B, Choe BH, Lee YJ, Park JH, Yang HR, Lee SH, Kim KM, Ryoo E, Tchah H, Shim JO, Koh H. Can We Estimate Quality of Life in Pediatric Inflammatory Bowel Disease Patients? An Asian Multicenter Study. J Pediatr Gastroenterol Nutr 2019;68:45-9. [PMID: 30052570 DOI: 10.1097/MPG.0000000000002119] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
|
21 |
Kim S, Park S, Kang Y, Kwon N, Koh H. Medical staff tend to underestimate the quality of life in children and adolescents with inflammatory bowel disease. Acta Paediatr 2019;108:138-42. [PMID: 29998507 DOI: 10.1111/apa.14498] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
|
22 |
Knowles SR, Keefer L, Wilding H, Hewitt C, Graff LA, Mikocka-Walus A. Quality of Life in Inflammatory Bowel Disease: A Systematic Review and Meta-analyses-Part II. Inflamm Bowel Dis 2018;24:966-76. [PMID: 29688466 DOI: 10.1093/ibd/izy015] [Cited by in Crossref: 93] [Cited by in F6Publishing: 85] [Article Influence: 18.6] [Reference Citation Analysis]
|
23 |
Merrick VM, Mortier K, Williams LJ, Muhammed R, Auth MKH, Elawad M, Fell JME, Beattie RM, Loganathan S, Torrente F, Morris MA, Charlton C, Croft NM, Rodrigues A, Furman M, Vadamalayan B, Jenkins H, Zamvar V, Mitton SG, Chong S, Cosgrove M, Akobeng A, Wilson DC, Russell RK. Real-life Anti-tumor Necrosis Factor Experience in More Than 500 Patients: High Co-immunosuppression Rates But Low Rates of Quantifying Treatment Response. J Pediatr Gastroenterol Nutr 2018;66:274-80. [PMID: 29356768 DOI: 10.1097/MPG.0000000000001679] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 1.2] [Reference Citation Analysis]
|
24 |
Uggla C, Lindh V, Lind T, Lindkvist M. IMPACT-III is a valid and reliable questionnaire for assessing health-related quality of life in Swedish children with inflammatory bowel disease. Acta Paediatr 2018;107:347-53. [PMID: 29032599 DOI: 10.1111/apa.14119] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
|
25 |
Carlsen K, Jakobsen C, Kallemose T, Paerregaard A, Riis LB, Munkholm P, Wewer V. F-calprotectin and Blood Markers Correlate to Quality of Life in Pediatric Inflammatory Bowel Disease. J Pediatr Gastroenterol Nutr 2017;65:539-45. [PMID: 28169974 DOI: 10.1097/MPG.0000000000001540] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
|
26 |
Chen XL, Zhong LH, Wen Y, Liu TW, Li XY, Hou ZK, Hu Y, Mo CW, Liu FB. Inflammatory bowel disease-specific health-related quality of life instruments: a systematic review of measurement properties. Health Qual Life Outcomes 2017;15:177. [PMID: 28915891 DOI: 10.1186/s12955-017-0753-2] [Cited by in Crossref: 45] [Cited by in F6Publishing: 50] [Article Influence: 7.5] [Reference Citation Analysis]
|
27 |
Grant A, Otley A. Measurement of Quality of Life in Pediatric Inflammatory Bowel Disease. In: Mamula P, Grossman AB, Baldassano RN, Kelsen JR, Markowitz JE, editors. Pediatric Inflammatory Bowel Disease. Cham: Springer International Publishing; 2017. pp. 625-38. [DOI: 10.1007/978-3-319-49215-5_51] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
28 |
Chouliaras G, Margoni D, Dimakou K, Fessatou S, Panayiotou I, Roma-Giannikou E. Disease impact on the quality of life of children with inflammatory bowel disease. World J Gastroenterol 2017; 23(6): 1067-1075 [PMID: 28246481 DOI: 10.3748/wjg.v23.i6.1067] [Cited by in CrossRef: 36] [Cited by in F6Publishing: 38] [Article Influence: 6.0] [Reference Citation Analysis]
|
29 |
Varni JW, Franciosi JP, Shulman RJ, Saeed S, Nurko S, Neigut DA, Bendo CB, Patel AS, Self MM, Saps M, Zacur GM, Denham J, Dark CV, Pohl JF; Pediatric Quality of Life Inventory Gastrointestinal Symptoms Module Testing Study Consortium. PedsQL gastrointestinal symptoms scales and gastrointestinal worry scales in pediatric patients with inflammatory bowel disease in comparison with healthy controls. Inflamm Bowel Dis 2015;21:1115-24. [PMID: 25793327 DOI: 10.1097/MIB.0000000000000351] [Cited by in Crossref: 32] [Cited by in F6Publishing: 25] [Article Influence: 4.0] [Reference Citation Analysis]
|
30 |
Abdovic S, Pavic AM, Milosevic M, Persic M, Senecic-Cala I, Kolacek S. Short health scale: a valid, reliable, and responsive measure of health-related quality of life in children with inflammatory bowel disease. Inflamm Bowel Dis 2015;21:818-23. [PMID: 25742398 DOI: 10.1097/MIB.0000000000000324] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
|
31 |
Wilburn J, Mckenna SP, Twiss J, Kemp K, Campbell S. Assessing quality of life in Crohn’s disease: development and validation of the Crohn’s Life Impact Questionnaire (CLIQ). Qual Life Res 2015;24:2279-88. [DOI: 10.1007/s11136-015-0947-1] [Cited by in Crossref: 25] [Cited by in F6Publishing: 29] [Article Influence: 3.1] [Reference Citation Analysis]
|
32 |
Szabó D, Kökönyei G, Arató A, Dezsőfi A, Molnár K, Müller KE, Lakatos PL, Papp M, Lovász BD, Golovics PA, Cseh A, Veres G. Autoregressive cross-lagged models of IMPACT-III and Pediatric Crohn's Disease Activity Indexes during one year infliximab therapy in pediatric patients with Crohn's disease. J Crohns Colitis 2014;8:747-55. [PMID: 24434181 DOI: 10.1016/j.crohns.2013.12.020] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.0] [Reference Citation Analysis]
|
33 |
Werner H, Landolt MA, Buehr P, Koller R, Nydegger A, Spalinger J, Heyland K, Schibli S, Braegger CP; Swiss IBD Cohort Study Group. Validation of the IMPACT-III quality of life questionnaire in Swiss children with inflammatory bowel disease. J Crohns Colitis 2014;8:641-8. [PMID: 24342766 DOI: 10.1016/j.crohns.2013.11.025] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 2.0] [Reference Citation Analysis]
|